DCM
KMTS

Driehaus Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Driehaus Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Buy
448,608
+1,293
+0.3% +$27.1K 0.07% 272
2026
Q1 		$8.91M Sell
447,315
-15,746
-3% -$371K 0.07% 274
2025
Q4 		$12.3M Buy
+463,061
New +$11.9M 0.08% 266

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Driehaus Capital Management's KMTS Position: Q2 2026 in Review

Driehaus Capital Management increased its Kestra Medical Technologies (KMTS) stake by 0.29% in Q2 2026, buying an estimated $27.1K and bringing the position to 448,608 shares worth $11.4M. The position accounts for 0.07% of the portfolio, ranked #272.

Driehaus Capital Management first reported a position in KMTS in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.3M in Q4 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Driehaus Capital Management held 448,608 shares of Kestra Medical Technologies worth $11.4M as of Q2 2026.
  • Driehaus Capital Management bought 1,293 Kestra Medical Technologies shares in Q2 2026, an estimated $27.1K.
  • Kestra Medical Technologies made up 0.07% of Driehaus Capital Management's portfolio in Q2 2026, its #272 holding.
  • Driehaus Capital Management first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 3 quarters since.
  • Driehaus Capital Management's Kestra Medical Technologies position peaked at $12.3M in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.